Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2-Reference-Cited by-同舟云学术

Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2

Published:2012-10-04 Issue:12 Volume:33 Page:2507-2519
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Killian Peter H.,Kronski Emanuel,Michalik Katharina M.,Barbieri Ottavia,Astigiano Simonetta,Sommerhoff Christian P.,Pfeffer Ulrich,Nerlich Andreas G.,Bachmeier Beatrice E.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/33/12/2507/17290881/bgs312.pdf

Reference53 articles.

1. Novel aspects for the application of Curcumin in chemoprevention of various cancers.;Bachmeier;Front. Biosci. (Schol. Ed).,2010

2. Curcumin for chemoprevention of colon cancer.;Johnson;Cancer Lett.,2007

3. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice.;Bachmeier;Cell. Physiol. Biochem.,2007

4. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.;Wilken;Mol. Cancer,2011

5. Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice.;Moghaddam;Carcinogenesis,2009

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin Inhibits Vasculogenic Mimicry via Regulating ETS-1 in Renal Cell Carcinoma;Current Cancer Drug Targets;2024-10

2. MicroRNA-532 as a probable diagnostic and therapeutic marker in cancer patients;Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis;2024-07

3. Advances in β‐diketocyclisation of curcumin derivatives and their Antitumor Activity;Chemistry & Biodiversity;2024-01-15

4. A blood-based multi-omic landscape for the molecular characterization of kidney stone disease;Molecular Omics;2024

5. Epigenetic changes driving therapy resistance in prostate cancer;Therapy Resistance in Prostate Cancer;2024